Atherectomy Devices Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type (Directional Atherectomy, Rotational Atherectomy, Orbital Atherectomy, Laser Atherectomy), By Application (Peripheral Vascular Applications, Cardiovascular Applications, and Neurovascular Applications) By End User (Hospitals and Surgical Centers, Ambulatory Care Centers, Research Laboratories, and Academic Institutes), and Region Forecast 2020-2031

Atherectomy Devices Market size was valued at US$ 828.1 million in 2024 and is expected to reach US$ 1,401.0 million by 2031, growing at a significant CAGR of 7.8% from 2025-2031. Moreover, the U.S. Atherectomy Devices Market is projected to grow significantly, reaching an estimated value of US$ 437.1 Million by 2031. The market is focused on medical devices used in atherectomy procedures, which are minimally invasive endovascular surgeries designed to remove atherosclerotic plaque from blood vessels, primarily arteries, to restore and improve blood flow. The market is primarily driven by the rising prevalence of peripheral artery disease (PAD), particularly among aging populations and patients with diabetes or obesity.

This surge in PAD cases has heightened the demand for minimally invasive plaque removal solutions, positioning atherectomy devices as a preferred treatment, especially for complex or calcified lesions. These devices offer significant clinical benefits such as vessel preservation, reduced stent dependency, and faster recovery. Complementing this driver is the trend toward integration of real-time imaging and navigation tools like IVUS and OCT into atherectomy systems. These technologies are improving procedural precision, safety, and confidence among physicians, while advancements in AI and device miniaturization are making procedures more efficient and accessible.

A major opportunity lies in the growing adoption of atherectomy procedures in outpatient and ambulatory surgical centers (ASCs), which offer cost-efficiency and improved patient convenience. Emerging markets in Asia-Pacific and Latin America also present growth potential due to improving healthcare infrastructure and increased awareness of PAD. However, high device costs and limited reimbursement availability remain significant restraints, particularly in resource-constrained settings. These factors, coupled with risks of procedural complications, may limit broader adoption despite the market’s promising outlook. Overall, the market is positioned for steady growth driven by innovation and shifting care models.

Facts & Figures:

• Rising Prevalence of Peripheral Artery Disease (PAD): PAD is affecting over 200 million people globally, driven by aging, diabetes, and sedentary lifestyles. This increases the need for advanced plaque removal solutions. For instance, according to the CDC, PAD prevalence has been rising significantly in the U.S. and Asia-Pacific, directly fueling demand for atherectomy procedures.
• Shift Toward Minimally Invasive Procedures: Healthcare providers and patients prefer less invasive options with faster recovery, and atherectomy devices meet this demand by enabling precise plaque removal without open surgery. For instance, Medtronic and AngioDynamics launched next-gen atherectomy devices optimized for outpatient use, reflecting this clinical preference.
• Favorable Reimbursement and Regulatory Approvals: Improved reimbursement policies in the U.S. and Europe support wider adoption of atherectomy systems across healthcare institutions. For instance, Cardio Flow’s FreedomFlow received U.S. FDA 510(k) clearance in late 2023, enabling commercialization with insurer support.
• Technological Advancements and Image-Guided Systems: Integration of IVUS, OCT, and AI allows better visualization and targeted treatment, enhancing success rates in complex cases. For instance, Avinger’s 2024 launch of Pantheris LV, the only image-guided directional atherectomy system, showcases innovation in real-time visualization technology.

Key Developments:

• In January 2025, Boston Scientific finalizes a $900 million acquisition of Bolt Medical, enhancing its portfolio with intravascular lithotripsy (IVL) technology to complement its atherectomy devices.
• In March 2024, Xtant Medical purchased Avinger, acquiring its advanced image-guided atherectomy technologies and strengthening its peripheral vascular device portfolio.
• In February 2024, Medtronic entered a collaboration with Biotronik to co-develop next-generation atherectomy systems, expanding their combined vascular intervention offerings.

Atherectomy Devices Market Segmentation:

Based on the type:

• Directional Atherectomy
• Rotational Atherectomy
• Orbital Atherectomy
• Laser Atherectomy

Among the different types, rotational atherectomy holds the largest market share in the market. This dominance is primarily due to its long-standing clinical use, effectiveness in treating heavily calcified lesions, and adaptability in both coronary and peripheral artery disease procedures. Its compatibility with various catheter-based platforms and growing adoption in outpatient settings further boost its utilization. Additionally, recent innovations in rotational technology and favorable reimbursement policies in developed markets support its continued growth. On the other hand, Laser Atherectomy currently holds the smallest market share, largely due to higher costs, limited availability, and the need for specialized operator training and equipment.

Based on the application:

• Peripheral Vascular Applications
• Cardiovascular Applications
• Neurovascular Applications

Peripheral Vascular Applications hold the largest market share in the market. This is largely attributed to the high and rising prevalence of peripheral artery disease (PAD), particularly among aging populations and individuals with diabetes or obesity. Atherectomy is especially effective in treating complex, calcified lesions in peripheral arteries where traditional angioplasty is less successful. Additionally, growing awareness, increasing adoption of minimally invasive procedures, and the shift toward outpatient treatments are driving demand in this segment. In contrast, Neurovascular Applications account for the smallest market share, as the technology is still emerging in this delicate and high-risk area with limited clinical use.

Based on the End User:

• Hospitals and Surgical Centers
• Ambulatory Care Centers
• Research Laboratories
• Academic Institutes

Based on end user, hospitals and surgical centers hold the largest market share in the market. These facilities are typically well-equipped with advanced infrastructure and trained personnel required for performing atherectomy procedures, particularly for complex cardiovascular and peripheral vascular cases. Their access to reimbursement programs and preference for technologically advanced, image-guided systems make them the primary channel for high-volume procedures. Hospitals also handle a majority of emergency and inpatient interventions, further boosting their market dominance. On the other hand, Research Laboratories and Academic Institutes represent the smallest market share, as their use of atherectomy devices is mostly limited to clinical trials, product testing, and medical training rather than routine procedures.